Peri-operative management of anti-platelet agents and anti-thrombotic agents in geriatric patients undergoing semi-urgent hip fracture surgery

Osteoporosis International

Volumn 21, Issue SUPPL. 4, 2010, Pages

  Ho, H H ^a   Lau, T W ^b,c   Leung, F ^c   Tse, H F ^b,c   Siu, C W ^b,c  

^a TAN TOCK SENG HOSPITAL   (Singapore)

^b UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Osteoporosis

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; DABIGATRAN; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; TICLOPIDINE;

BLEEDING; CARDIOVASCULAR DISEASE; COMORBIDITY; CORONARY STENT; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG COST; DRUG HALF LIFE; GERIATRIC PATIENT; HIP ARTHROPLASTY; HIP FRACTURE; HIP SURGERY; HOSPITALIZATION; HUMAN; INCIDENCE; LUNG EMBOLISM; MORBIDITY; MORTALITY; PERIOPERATIVE COMPLICATION; PERIOPERATIVE PERIOD; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; PROPHYLAXIS; REGIONAL ANESTHESIA; REVIEW; SPINAL HEMATOMA; STENT THROMBOSIS; THROMBOEMBOLISM; VENOUS THROMBOEMBOLISM;

AGED; ANESTHESIA, CONDUCTION; FIBRINOLYTIC AGENTS; HIP FRACTURES; HUMANS; OSTEOPOROTIC FRACTURES; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; THROMBOEMBOLISM;

EID: 78449309379     PISSN: 0937941X     EISSN: 14332965     Source Type: Journal    
DOI: 10.1007/s00198-010-1416-x     Document Type: Review

References (36)

1. GL Lu-Yao JA Baron JA Barrett ES Fischer 1994 Treatment and survival among elderly Americans with hip fractures: a population-based study Am J Public Health 84 1287 1:STN:280:DyaK2czjslyqtw%3D%3D 10.2105/AJPH.84.8.1287 8059887
2. J Magaziner EM Simonsick TM Kashner, et al. 1990 Predictors of functional recovery one year following hospital discharge for hip fracture: a prospective study J Gerontol 45 M101 1:STN:280:DyaK3c3ksVSltw%3D%3D 2335719
3. J Magaziner W Hawkes JR Hebel, et al. 2000 Recovery from hip fracture in eight areas of function J Gerontol A Biol Sci Med Sci 55A M498 M507
4. AH Morris JD Zuckerman 2002 National consensus conference on improving the continuum of care for patients with hip fracture J Bone Joint Surg Am 84-A 670 674 11940633
5. RS Morrison MR Chassin AL Siu 1998 The medical consultant's role in caring for patients with hip fracture Ann Intern Med 128 1010 1:STN:280:DyaK1c3ntlyguw%3D%3D 9625664
6. FM Davis DF Woolner C Frampton, et al. 1987 Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly Br J Anaesth 59 1080 1:STN:280:DyaL1c%2FisVKisw%3D%3D 10.1093/bja/59.9.1080 3311100
7. C Bredahl B Nyholm KB Hindsholm, et al. 1992 Mortality after hip fracture: results of operation within 12 h of admission Injury 23 83 1:STN:280:DyaK383ktF2rug%3D%3D 10.1016/0020-1383(92)90037-S 1572720
8. FB Rogers SR Shackford MS Keller 1995 Early fixation reduces morbidity and mortality in elderly patients with hip fractures from low-impact falls J Trauma 39 261 1:STN:280:DyaK2MvgsVOisg%3D%3D 10.1097/00005373-199508000-00012 7674394
9. A Bottle P Aylin 2006 Mortality associated with delay in operation after hip fracture: observational study BMJ 332 947 10.1136/bmj.38790.468519.55 16554334 (Pubitemid 44365552)
10. T Shiga Z Wajima Y Ohe 2008 Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis and meta-regression Can J Anaesth 5 146
11. Anonymous (1994) Collaborative overview of randomized trials of anti-platelet therapy-III: reduction in venous thrombosis and pulmonary embolism by antiplatelet prophylaxis among surgical and medical patients. Antiplatelet Trialists' Collaboration. BMJ 308:235
12. JC Merritt DL Bhatt 2004 The efficacy and safety of perioperative antiplatelet therapy J Thromb Thrombolysis 17 21 27 1:CAS:528: DC%2BD2cXlvF2hurg%3D 10.1023/B:THRO.0000036025.07348.f1 15277784 (Pubitemid 39069458)
13. GL Kaluza J Joseph JR Lee ME Raizner AE Raizner 2000 Catastrophic outcomes of noncardiac surgery soon after coronary stenting J Am Coll Cardiol 35 1288 1294 1:STN:280:DC%2BD3c3itVOhsw%3D%3D 10.1016/S0735-1097(00)00521-0 10758971 (Pubitemid 30206904)
14. MN Vicenzi D Ribitsch O Luha W Klein H Metzler 2001 Coronary artery stenting before noncardiac surgery: more threat than safety? Anaesthesiology 94 367 368 1:STN:280:DC%2BD3M7ktFOjsw%3D%3D 10.1097/00000542-200102000-00035
15. PR Reddy PT Vaitkus 2005 Risks of noncardiac surgery after coronary stenting Am J Cardiol 95 755 757 10.1016/j.amjcard.2004.11.029 15757604 (Pubitemid 40332656)
16. MJ Brown TR Long DR Brown CT Wass 2006 Acute coronary syndrome and myocardial infarction after orthopaedic surgery in a patient with a recently placed drug-eluting stent J Clin Anesth 18 537 540 10.1016/j.jclinane.2006.03. 011 17126785 (Pubitemid 44780095)
17. T Lecompte J-F Hardy 2006 Antiplatelet agents and perioperative bleeding Can J Anaesth 53 6 Suppl S103 S112 16766783
18. LA Fleisher JA Beckman KA Brown H Calkins E Chaikof KE Fleishmann WK Freeman JB Froehlich E Kasper JR Kersten B Riegel JF Robb 2007 ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery) Circulation 116 e418 e499 10.1161/CIRCULATIONAHA.107.185699 17901357
19. JP Collet G Montalescot 2006 Premature withdrawal and alternative therapies to dual oral antiplatelet therapy Eur Heart J Suppl 8 Suppl G46 G52 1:CAS:528:DC%2BD28Xht1OksrzI 10.1093/eurheartj/sul055 (Pubitemid 44526986)
20. KN Charbucinska G Godet O Itani NJ Fleron M Bertrand M Rienzo P Coriat 2006 Anticoagulation management for patients with drug-eluting stents undergoing vascular surgery Anesth Analg 103 261 263 10.1213/01.ANE.0000215214.87584.E5 16790679 (Pubitemid 44036088)
21. P Albaladejo E Marret V Piriou CM Samama 2006 French Society of Anesthesiology and Intensive Care. Management of oral antiplatelet agents in patients with coronary stents: recommendations of a French Task Force Ann Fr Anesth Reanim 25 7 796 798 1:STN:280:DC%2BD28vptlOrsA%3D%3D 16919752
22. P-G Chassot A Delabays DR Spahn 2007 Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction Br J Anaesth 99 316 328 1:CAS:528:DC%2BD2sXpt1Cltrw%3D 10.1093/bja/aem209 17650517 (Pubitemid 47321534)
23. L Broad T Lee M Conroy S Bolsin N Orford A Black G Birdsey 2007 Successful management of patients with a drug-eluting coronary stent presenting for elective, non-cardiac surgery Br J Anaesth 98 19 22 1:STN:280: DC%2BD28jhvFShtw%3D%3D 10.1093/bja/ael318 17124186 (Pubitemid 44896746)
24. ES Brilakis S Banerjee PB Berger 2007 Perioperative management of patients with coronary stents J Am Coll Cardiol 49 2145 2150 10.1016/j.jacc.2007.02.046 17543633 (Pubitemid 46824115)
25. WH Geerts GF Pineo JA Heit, et al. 2004 Prevention of venous thromboembolism: the Seventh ACCP Conference of Antithrombotic and Thrombolytic Therapy Chest 126 338S 1:CAS:528:DC%2BD2cXptV2msbw%3D 10.1378/chest.126.3-suppl. 338S 15383478 (Pubitemid 39302602)
26. WH Geerts D Bergqvist GF Pineo, et al. 2008 Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest 133 381S 1:CAS:528:DC%2BD1cXptVKhsrg%3D 10.1378/chest.08-0656 18574271 (Pubitemid 351894916)
27. BI Eriksson KA Bauer MR Lassen AG Turpie 2001 Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery N Engl J Med 345 1298 1:CAS:528:DC%2BD3MXnvV2ltr0%3D 10.1056/NEJMoa011100 11794148
28. R Collins A Scrimgeour S Yusuf R Peto 1988 Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin: overview of results of randomized trials in general, orthopaedic and urologic surgery N Engl J Med 318 1162 1:STN:280:DyaL1c3gt1Sgsg%3D%3D 10.1056/NEJM198805053181805 3283548
29. Handoll HH, Farrar MJ, McBirnie J et al (2002) Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev (4):CD000305
30. BI Eriksson OE Dahl N Rosencher, et al. 2007 Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomized, double-blind, non-inferiority trial Lancet 370 949 1:CAS:528:DC%2BD2sXhtVeqsL7F 10.1016/S0140-6736(07)61445-7 17869635 (Pubitemid 47393577)
31. R Kohrs CW Hoenemann N Feirer ME Durieux 1999 Bupivacaine inhibits whole blood coagulation in vitro Reg Anesth Pain Med 24 326 330 1:CAS:528: DyaK1MXltVKisbs%3D 10445771
32. T Borg J Modig 1985 Potential anti-thrombotic effects of local anaesthetics due to their inhibition of platelet aggregation Acta Anaesthesiol Scand 29 739 742 1:CAS:528:DyaL28XkvFM%3D 10.1111/j.1399-6576.1985.tb02292.x 4072600
33. TT Horlocker DJ Wedel H Benzon DL Brown FK Enneking JA Heit MF Mulroy RW Rosenquist J Rowlingson M Tryloa CS Yuan 2003 Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation) Reg Anesth Pain Med 28 172 197 12772135
34. JD Douketis F Dentali 2006 Managing anticoagulant and antiplatelet drugs in patients who are receiving neuraxial anesthesia and epidural analgesia: a practical guide for clinicians Tech Reg Anesth Pain Manag 10 46 55 10.1053/j.trap.2006.04.004
35. EP Vandermeulen H Van Aken J Vermylen 1994 Anticoagulants and spinal-epidural anesthesia Anesth Analg 79 1165 1177 1:STN:280: DyaK2M%2FmvFWhtg%3D%3D 10.1213/00000539-199412000-00024 7978443
36. SL Nightingale 1998 From the food and drug administration JAMA 279 346 1:STN:280:DyaK1c7hvFGnsQ%3D%3D 10.1001/jama.279.5.346 9459455 (Pubitemid 28133855)